Investors & Media

May 18, 2018 10:09 AM EDT

Copyright Nasdaq. Minimum 15 minutes delayed.

Investors & Media

SEC Filing Details

SEC Filing Details

Document Details

Filing Date
Feb 1, 2018
Document Date
Feb 1, 2018
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
Keryx Biopharmaceuticals, Inc.
Issuer
KERYX BIOPHARMACEUTICALS INC